chr11-116757907-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_032725.4(BUD13):āc.1543A>Gā(p.Met515Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,614,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_032725.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BUD13 | NM_032725.4 | c.1543A>G | p.Met515Val | missense_variant | 8/10 | ENST00000260210.5 | |
BUD13 | NM_001159736.2 | c.1141A>G | p.Met381Val | missense_variant | 8/10 | ||
BUD13 | XM_011543035.3 | c.1444A>G | p.Met482Val | missense_variant | 8/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BUD13 | ENST00000260210.5 | c.1543A>G | p.Met515Val | missense_variant | 8/10 | 1 | NM_032725.4 | P2 | |
BUD13 | ENST00000375445.7 | c.1141A>G | p.Met381Val | missense_variant | 8/10 | 1 | A2 | ||
BUD13 | ENST00000419189.1 | c.320A>G | p.Asn107Ser | missense_variant, NMD_transcript_variant | 2/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251458Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135908
GnomAD4 exome AF: 0.000116 AC: 169AN: 1461864Hom.: 0 Cov.: 31 AF XY: 0.000122 AC XY: 89AN XY: 727234
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74362
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at